Keikawus Arastéh

机构：St. Joseph-Krankenhaus, Charité - Universitätsmedizin Berlin

发表论文 655 篇 · 总被引 5614 次 · h-index 40

代表论文

• Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection (2020 · New England Journal of Medicine · 被引 483)
• Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials (2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 157)
• Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial (2019 · The Lancet HIV · 被引 99)
• Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial (2023 · ˜The œLancet. Gastroenterology & hepatology · 被引 82)
• A highly virulent variant of HIV-1 circulating in the Netherlands (2022 · Science · 被引 76)
• Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study (2021 · Open Forum Infectious Diseases · 被引 64)